AI-28 RECURRENT GLIOBLASTOMAS AFTER TREATMENT WITH BEVACIZUMAB

Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, has been evaluated in the treatment of patients with primary or recurrent glioblastoma. We aimed to characterize neuropathological and molecular features in recurrent malignant gliomas after failure of Bevacizumab tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tabatabai, Ghazaleh, Felsberg, Jörg, Sabel, Michael, Kaulich, Kerstin, Hofer, Silvia, Westphal, Manfred, Weller, Michael, Reifenberger, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217867/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou238.28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados